Remove 2025 Remove Invention Remove Patent
article thumbnail

USPTO’s Final Rule on FY 2025 Patent Fees Drops Divisive Proposals for Across-the-Board Hikes

IP Watchdog

Patent and Trademark Office (USPTO) today published a final rule announcing across-the-board fee increases of 7.5% The changes will take effect as of January 19, 2025. but scrapping the most controversial proposals from its April 2024 Notice of Proposed Rulemaking (NPRM).

Patent 104
article thumbnail

CRI Guidelines 2025 is out for Public Consultations!

SpicyIP

On 25th March 2025, the Patent Office officially released the Draft Guidelines for Examination of Computer-Related Inventions (CRI), 2025 , for public consultations. On a quick glance at the guidelines, the guidelines include discussion surrounding all aspects of patenting software (novelty, inventive step, clarity, etc).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Madras High Court holds that not all inventions must yield physical products to be patentable

Selvam & Selvam Blog

Robert Bosch Limited, filed an appeal before the Madras High Court, challenging the rejection of their Indian Patent Application No. The FER also cited Section 3(d), excluding claims 1 to 6 from patentability. Counsel for the appellant argued that the Controller erred in applying Section 3(m) to the claimed invention.

article thumbnail

Supreme Court Patent Challenges February 2025

Patently-O

by Dennis Crouch The Supreme Court's 2024-2025 patent docket has a growing number of cases awaiting consideration. I count fifteen pending cases that could reshape multiple facets of patent law. Celanese raises questions the the scope of the on-sale bar under the America Invents Act, particularly for secret processes.

Patent 52
article thumbnail

Recor Medical, Inc. v. Medtronic Ireland Mfg. (Fed. Cir. 2025)

JD Supra Law

Theinter partesreview provisions of the Leahy-Smith America Invents Act have been criticized for the propensity of the Patent Trial and Appeal Board (PTAB) to find invalid all or at least some of the challenged claims, frequently on obviousness grounds.Failure to so find, in addition to being less common has also often upheld on appeal, in view of (..)

article thumbnail

A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine

SpicyIP

Rajya Sabha MP Haris Beeran wrote to the Minister of Health and Family Welfare on December 20, 2024, urging the Central Government to invoke Section 100 (1) of the Patents Act with respect to local production of the rare disease Spinal Muscular Atrophy (SMA) treating drug Risdiplam. The next date of hearing is today, i.e. January 20, 2025.

article thumbnail

USPTO Fees Increasing on January 19, 2025: Key Changes to Note

JD Supra Law

The United States Patent and Trademark Office (USPTO) announced an increase in patent fees to take effect on January 19, 2025.

Invention 105